| Robert Facer Jensen, NP | |
|
6071 E Woodmen Rd Ste 105, Colorado Springs, CO 80923-2610 | |
| (719) 597-8704 | |
| (719) 597-6864 |
| Full Name | Robert Facer Jensen |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 6071 E Woodmen Rd Ste 105, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760853600 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SF0001X | Clinical Nurse Specialist - Family Health | APN.0991980-NP (Colorado) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 0991980 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert Facer Jensen, NP 6071 E. Woodmen Rd., Colorado Springs, CO 80923 Ph: (719) 590-1177 | Robert Facer Jensen, NP 6071 E Woodmen Rd Ste 105, Colorado Springs, CO 80923-2610 Ph: (719) 597-8704 |
News Archive
A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.
Celgene Corporation today announced that after consultation with the U.S. Food and Drug Administration Celgene will discontinue treatment with REVLIMID (lenalidomide) in the open-label, phase III ORIGIN trial, which enrolled 450 patients in over 100 sites in 26 countries.
Finding molecules that block the activity of the oncogene Stat 3 (signal transducer and activator of transcription) required screening literally millions of compounds, using computers that compared the structure of the cancer-causing gene to those of the small molecules, said a Baylor College of Medicine researcher in a report that appears in the current online issue of the journal PLoS One (Public Library of Science ONE).
Intrinsic Bioprobes today announced that the United States Patents and Trademark Office has issued US Patent 7,816,095 covering novel blood protein biomarkers related to cardiovascular disease. This patent is first of a series of patent applications that cover specific human protein variants as biomarkers with clinical utility.
› Verified 3 days ago
Barbara J Starkey, MSN, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 125 Swope Ave, Colorado Springs, CO 80909 Phone: 719-634-4746 Fax: 719-634-5024 | |
Melinda Mcclendon, RN, AGNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4110 Briargate Pkwy Ste 405, Colorado Springs, CO 80920 Phone: 719-365-7300 Fax: 512-275-2833 | |
Jennifer Turnbaugh, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3425 Austin Bluffs Pkwy, Colorado Springs, CO 80918 Phone: 719-265-4412 Fax: 719-888-1739 | |
Sonia Singh, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1650 Cochrane Cir Unit Meddac, Colorado Springs, CO 80913 Phone: 719-526-7000 | |
Carole Traylor, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6071 E. Woodmen Rd, Suite 105, Colorado Springs, CO 80923 Phone: 719-597-8704 Fax: 719-597-6864 | |
Mrs. Rebecca Stone, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3700 Galley Rd, Colorado Springs, CO 80909 Phone: 719-591-2724 | |
Jason F Blair, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4740 Flintridge Dr Ste 130, Colorado Springs, CO 80918 Phone: 719-917-1000 |